01 Rise in Safety-Engineered and Retractable Needles One of the most significant trends in the market for needles is the shift toward safety-engineered and retractable needles. Healthcare worker safety has come under increased scrutiny due to rising cases of needlestick injuries, which, according to the WHO, result in over 2 million exposures annually to bloodborne pathogens. Regulatory bodies like OSHA in the U.S. and the EU’s Council Directive 2010/32/EU have mandated the use of safer needle devices to combat this. Companies are responding by innovating needle designs that retract after use or feature protective shields. For instance, in March 2025, Becton, Dickinson and Company (BD)announced an expansion of its Integra™ retractable syringe needle portfolio designed to enhance healthcare worker safety by minimising needlestick injuries. This product line is gaining adoption in hospitals and vaccination centers globally. Moreover, rising vaccination programs globally have prompted the adoption of auto-disable and retractable needles in low-resource settings, further amplifying this trend. The demand for such advanced products will likely escalate as awareness and regulations strengthen across emerging markets.
June 2026 Becton, Dickinson and Company (BD) expanded its needle and injection device portfolio by advancing safety-engineered needle technologies and drug delivery solutions. The company focused on improving healthcare worker safety, injection accuracy, and patient care efficiency.
May 2026 Terumo expanded its medical device portfolio by advancing hypodermic needles, specialty needles, and injection technologies. The initiatives focused on improving precision, reliability, and usability across clinical and healthcare applications.
April 2026 Nipro expanded its medical consumables portfolio through advancements in needle manufacturing technologies and injection-related products. The company focused on improving product quality, safety features, and accessibility for healthcare providers.
January 2026 B. Braun expanded its injection and infusion therapy portfolio by advancing needle technologies and medication delivery solutions. The company focused on enhancing safety, performance, and efficiency in healthcare procedures.